|
FDA Approves New Anthrax Vaccine for Adults Despite Lack of Publicly Available Information on Testing, Ingredients
 [ChildrensHealthDefense] The vaccine, Cyfendus, is approved for use after suspected or confirmed exposure to Bacillus anthracis, also known as anthrax, but must be administered together with other antibacterial drugs.Emergent said it had been delivering Cyfendus to the U.S. Department of Health and Human Services (HHS) since 2019, under pre-emergency use authorization status. The efficacy of Cyfendus for post-exposure prophylaxis was tested only on animals. Emergent said the drug has been in development for 20 years in collaboration with the Defense Advanced Research Projects Agency (DARPA), the Biomedical Advanced Research and Development Authority (BARDA), and the National Institute of Allergy and Infectious Diseases (NIAID), formerly headed by Dr. Anthony Fauci. Paul Williams, senior vice president at Emergent, said anthrax “remains a high-priority national security threat.” Cyfendus is comprised of Emergent’s anthrax vaccine adsorbed (AVA), marketed as Biothrax, plus an additional adjuvant, the name of which the company did not disclose. Cyfendus is administered in two doses over 14 days to elicit an immune response that the company said: “can be especially important in response to a large-scale public health emergency involving anthrax.” Nass said that during the 2001 anthrax scare, where politicians and media organizations across the country received anthrax in the mail, five people died — but “everyone who got antibiotics early did not come down with anthrax and none of them died.”
Related: FDA: 2023-07-21 'The deadliest threat America's ever faced': Mass-produced in China, trafficked from Puerto Rico and available online for just $1 a KILO ‐ why the flesh-rotting zombie drug 'tranq' has the DEA terrified FDA: 2023-07-20 FDA Approves Remdesivir for COVID Treatment in People With Kidney Disease FDA: 2023-07-14 Maybelline under fire for using bearded model in ad after Dylan Mulvaney flap Posted by: NN2N1 2023-07-23 |
|
| http://www.rantburg.com/poparticle.php?ID=673344 |